Clinical Experience With Nintedanib For Idiopathic Pulmonary Fibrosis In 3 Uk Tertiary Interstitial Lung Disease Centres

被引：0
|
作者：
Toellner, H. [1 ]
Beswick, W. [2 ]
Crooks, M. [2 ]
Donaldson, C. [3 ]
Forrest, I. [3 ]
Hart, S. [2 ]
Leonard, C.
Major, M. [2 ]
Simpson, A. [3 ]
Chaudhuri, N. [4 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[3] Newcastle Upon Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Hosp South Manchester, Wythenshawe, Scotland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5384
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Brunnemer, Eva
    Waelscher, Julia
    Tenenbaum, Svenja
    Hausmanns, Julia
    Schulze, Karen
    Seiter, Marianne
    Heussel, Claus Peter
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    RESPIRATION, 2018, 95 (05) : 301 - 309
  • [42] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [43] Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
    Brown, Kevin K.
    Flaherty, Kevin R.
    Cottin, Vincent
    Raghu, Ganesh
    Inoue, Yoshikazu
    Azuma, Arata
    Huggins, John T.
    Richeldi, Luca
    Stowasser, Susanne
    Stansen, Wibke
    Schlenker-Herceg, Rozsa
    Maher, Toby M.
    Wells, Athol U.
    RESPIRATORY MEDICINE, 2019, 146 : 42 - 48
  • [44] Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
    Mullerpattan, Jai B.
    Porwal, Sana H.
    Sarkar, Trina A.
    Wagh, Haresh D.
    Udwadia, Zarir F.
    LUNG INDIA, 2019, 36 (05) : 465 - +
  • [45] Survival in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Interstitial Lung Disease
    Carbone, Roberto Giovanni
    Filiberti, Rosangela
    Chiola, Silvia
    Pariscenti, Gian Luca
    Sambuceti, Gianmario
    Puppo, Francesco
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [46] Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis
    Spagnolo, Paolo
    Wuyts, Wim
    CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (05) : 411 - 417
  • [47] CYTOKINES IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Zheng, B.
    Keen, K.
    Fritzler, M.
    Ryerson, C.
    Wilcox, P.
    Whalen, B.
    Sahin, B.
    Hou, H.
    Latham, P.
    Zhang, M. F.
    Yao, I.
    Dunne, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 729 - 729
  • [48] Progression in Interstitial Lung Disease - Comparison of Rheumatoid Arthritis with Idiopathic Pulmonary Fibrosis
    Dubey, Shirish
    Woodhead, Felix
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
    Bando, Tomohiro
    Takei, Reoto
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kataoka, Kensuke
    Kimura, Tomoki
    Johkoh, Takeshi
    Fukuoka, Junya
    Kondoh, Yasuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] COMPARISON OF CLINICAL CHARACTERISTICS BETWEEN IDIOPATHIC PULMONARY FIBROSIS AND OTHER INTERSTITIAL LUNG DISEASE AMONG PATIENTS WITH LUNG CANCER
    Han, Soojin
    Hyun, Dong-gon
    Choi, Changmin
    Lee, Jae Cheol
    Kim, Hocheol
    CHEST, 2023, 164 (04) : 3093A - 3093A
12345